DYNE THERAPEUTICS INC. - COMMON STOCK
29.85
25-十一月-24 10:24:00
15 分钟延时
股票
+0.16
+0.54%
今日范围
29.19 - 30.77
ISIN
N/A
来源
NASDAQ
-
Dyne Therapeutics Reports Third Quarter 2024 Financial Results and Provides Corporate Update
12 11月 2024 07:30:00 条件 Nasdaq GlobeNewswire
-
Dyne Therapeutics to Present at Upcoming Investor Conferences
07 11月 2024 16:15:00 条件 Nasdaq GlobeNewswire
-
09 10月 2024 07:30:00 条件 Nasdaq GlobeNewswire
-
Dyne Therapeutics to Present at Chardan’s 8th Annual Genetic Medicines Conference
23 9月 2024 08:56:28 条件 Nasdaq GlobeNewswire
-
Dyne Therapeutics Announces Key Leadership Appointments
03 9月 2024 06:31:00 条件 Nasdaq GlobeNewswire
-
Dyne Therapeutics to Present at Morgan Stanley 22nd Annual Global Healthcare Conference
29 8月 2024 07:30:00 条件 Nasdaq GlobeNewswire
-
Dyne Therapeutics Reports Second Quarter 2024 Financial Results and Recent Business Highlights
12 8月 2024 17:10:00 条件 Nasdaq GlobeNewswire
-
24 6月 2024 07:30:00 条件 Nasdaq GlobeNewswire
-
13 6月 2024 16:40:00 条件 Nasdaq GlobeNewswire
-
Dyne Therapeutics to Present at Jefferies Global Healthcare Conference
30 5月 2024 07:30:00 条件 Nasdaq GlobeNewswire
-
28 5月 2024 07:30:00 条件 Nasdaq GlobeNewswire
-
Dyne Therapeutics Announces Pricing of $325.5 Million Public Offering of Common Stock
21 5月 2024 20:39:57 条件 Nasdaq GlobeNewswire
-
Dyne Therapeutics Announces Proposed Public Offering of Common Stock
20 5月 2024 16:01:00 条件 Nasdaq GlobeNewswire
-
19 5月 2024 08:00:00 条件 Nasdaq GlobeNewswire
-
Dyne Therapeutics Reports First Quarter 2024 Financial Results and Recent Business Highlights
02 5月 2024 16:10:00 条件 Nasdaq GlobeNewswire
-
27 3月 2024 16:05:00 条件 Nasdaq GlobeNewswire
-
Dyne Therapeutics to Present at the Cantor Virtual Muscular Dystrophy Symposium
27 3月 2024 08:30:00 条件 Nasdaq GlobeNewswire
-
Dyne Therapeutics Announces CEO Transition
25 3月 2024 07:30:00 条件 Nasdaq GlobeNewswire
- <<
- <
- 1
- >